Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Ground-Glass Opacity Lung Nodules in the Era of Lung Cancer CT Screening: Radiology, Pathology, and Clinical Management.

Pedersen JH, Saghir Z, Wille MM, Thomsen LH, Skov BG, Ashraf H.

Oncology (Williston Park). 2016 Mar;30(3):266-74. Review.

2.

Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.

Wille MM, Dirksen A, Ashraf H, Saghir Z, Bach KS, Brodersen J, Clementsen PF, Hansen H, Larsen KR, Mortensen J, Rasmussen JF, Seersholm N, Skov BG, Thomsen LH, Tønnesen P, Pedersen JH.

Am J Respir Crit Care Med. 2016 Mar 1;193(5):542-51. doi: 10.1164/rccm.201505-1040OC.

PMID:
26485620
3.

The prevalence of EGFR mutations in non-small cell lung cancer in an unselected Caucasian population.

Skov BG, Høgdall E, Clementsen P, Krasnik M, Larsen KR, Sørensen JB, Skov T, Mellemgaard A.

APMIS. 2015 Feb;123(2):108-15. doi: 10.1111/apm.12328. Epub 2014 Nov 25.

PMID:
25421919
4.

[Lung cancer screening with low-dose CT - Danish and international results].

Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, Døssing M, Hansen H, Kofoed KF, Larsen KR, Mortensen J, Rasmussen JF, Thomsen LH, Wille MM, Seersholm N, Skov BG, Thorsen H, Tønnesen P, Pedersen JH.

Ugeskr Laeger. 2014 Oct 13;176(42). pii: V05140283. Danish.

PMID:
25316371
5.

[Lung cancer screening with low dose CT requires careful consideration].

Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, Døssing M, Hansen H, Kofoed KF, Larsen KR, Mortensen J, Rasmussen JF, Thomsen LH, Wille MM, Seersholm N, Skov BG, Thorsen H, Tønnesen P, Pedersen JH.

Ugeskr Laeger. 2014 Oct 13;176(42). pii: V06140341. Danish.

PMID:
25316363
6.

High specificity but low sensitivity of mutation-specific antibodies against EGFR mutations in non-small-cell lung cancer.

Bondgaard AL, Høgdall E, Mellemgaard A, Skov BG.

Mod Pathol. 2014 Dec;27(12):1590-8. doi: 10.1038/modpathol.2014.67. Epub 2014 Apr 25.

7.

Endobronchial ultrasound-guided biopsy performed under optimal conditions in patients with known or suspected lung cancer may render mediastinoscopy unnecessary.

Clementsen PF, Skov BG, Vilmann P, Krasnik M.

J Bronchology Interv Pulmonol. 2014 Jan;21(1):21-5. doi: 10.1097/LBR.0000000000000028.

PMID:
24419182
8.
9.
10.

Multicenter randomized controlled trial comparing the performance of 22 gauge versus 25 gauge EUS-FNA needles in solid masses.

Vilmann P, Săftoiu A, Hollerbach S, Skov BG, Linnemann D, Popescu CF, Wellmann A, Gorunescu F, Clementsen P, Freund U, Flemming P, Hassan H, Gheonea DI, Streba L, Ioncică AM, Streba CT.

Scand J Gastroenterol. 2013 Jul;48(7):877-83. doi: 10.3109/00365521.2013.799222.

PMID:
23795663
11.

CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.

Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, Døssing M, Hansen H, Kofoed KF, Larsen KR, Mortensen J, Rasmussen JF, Seersholm N, Skov BG, Thorsen H, Tønnesen P, Pedersen JH.

Thorax. 2012 Apr;67(4):296-301. doi: 10.1136/thoraxjnl-2011-200736. Epub 2012 Jan 27.

PMID:
22286927
12.

International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report.

Field JK, Smith RA, Aberle DR, Oudkerk M, Baldwin DR, Yankelevitz D, Pedersen JH, Swanson SJ, Travis WD, Wisbuba II, Noguchi M, Mulshine JL; IASLC CT Screening Workshop 2011 Participants.

J Thorac Oncol. 2012 Jan;7(1):10-9. doi: 10.1097/JTO.0b013e31823c58ab.

13.

The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group.

Thunnissen E, Kerr KM, Herth FJ, Lantuejoul S, Papotti M, Rintoul RC, Rossi G, Skov BG, Weynand B, Bubendorf L, Katrien G, Johansson L, López-Ríos F, Ninane V, Olszewski W, Popper H, Jaume S, Schnabel P, Thiberville L, Laenger F.

Lung Cancer. 2012 Apr;76(1):1-18. doi: 10.1016/j.lungcan.2011.10.017. Epub 2011 Dec 3. Review.

PMID:
22138001
14.

Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers.

Rohrberg KS, Olesen RK, Pfeiffer P, Ladekarl M, Pappot H, Christensen IJ, Høyer-Hansen G, Sørensen M, Skov BG, Buysschaert I, Carmeliet P, Lassen U.

Acta Oncol. 2012 Feb;51(2):234-42. doi: 10.3109/0284186X.2011.619568. Epub 2011 Oct 21.

PMID:
22017239
15.

Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab.

Rohrberg KS, Pappot H, Lassen U, Westman M, Olesen RK, Pfeiffer P, Ladekarl M, Sørensen M, Christensen IJ, Skov BG.

Cancer Biol Ther. 2011 Apr 15;11(8):732-9. Epub 2011 Apr 15.

PMID:
21330783
16.

Markers of angiogenesis and epidermal growth factor receptor signalling in patients with pancreatic and gastroesophageal junction cancer.

Rohrberg KS, Skov BG, Lassen U, Christensen IJ, Høyer-Hansen G, Buysschaert I, Pappot H.

Cancer Biomark. 2010;7(3):141-51. doi: 10.3233/CBM-2010-0157.

PMID:
21263190
17.

Different expression of EZH2, BMI1 and Ki67 in low and high grade neuroendocrine tumors of the lung.

Bondgaard AL, Poulsen TT, Poulsen HS, Skov BG.

Cancer Biomark. 2012;11(2-3):123-8.

PMID:
23011159
18.

Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial.

Fischer BM, Mortensen J, Hansen H, Vilmann P, Larsen SS, Loft A, Bertelsen AK, Ravn J, Clementsen P, Høegholm A, Larsen KR, Dirksen A, Skov BG, Krasnik M, Højgaard L, Lassen U.

Thorax. 2011 Apr;66(4):294-300. doi: 10.1136/thx.2010.154476. Epub 2010 Dec 17.

PMID:
21169287
19.

Giant solitary fibrous tumour of the pleura: a rare but usually benign intrathoracic neoplasm.

Bodtger U, Pedersen JH, Skov BG, Clementsen P.

Clin Respir J. 2009 Apr;3(2):109-11. doi: 10.1111/j.1752-699X.2008.00104.x.

PMID:
20298386
20.

ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.

Skov BG, Holm B, Erreboe A, Skov T, Mellemgaard A.

J Thorac Oncol. 2010 Apr;5(4):453-9. doi: 10.1097/JTO.0b013e3181ca063b.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk